64 results
8-K
EX-99.1
LSTA
Lisata Therapeutics Inc
14 Aug 23
Lisata Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
4:08pm
Nanocomplex (TPN) Platform Technology Transfer
The tumor penetrating nanocomplex (TPN) platform targets intracellular delivery of RNA-based drugs
8-K/A
EX-99.1
LSTA
Lisata Therapeutics Inc
4 Oct 22
Other Events
4:42pm
anticancer tumor targets. With alternative CendR targeting moieties, it has also been used by Cend and its collaborators to deliver RNA-based drugs … compete with CEND-1, but have failed in the clinic. Cend’s technology is based on a different principle: CEND-1 targets its effects to tumor via affinity
8-K
EX-99.1
ap3oucveb5tlcz73 eh1
22 Sep 22
Regulation FD Disclosure
4:02pm
8-K
EX-99.2
iy0o7pgda50hhw3
15 Sep 22
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
9:16am
8-K
EX-99.3
39b pvp5u
5 Aug 22
Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
4:01pm
424B3
k9v83pioohq
29 Jul 22
Prospectus supplement
4:06pm
8-K
EX-99.2
rxj5xhbij126vatb
23 May 22
Caladrius Biosciences Provides Update on Phase 2b FREEDOM Trial of XOWNA® in Coronary Microvascular Dysfunction
4:08pm
8-K
EX-99.2
1rud4jzsvpjaprbo2c1b
5 May 22
Caladrius Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update
12:00am
425
t7trlh82qvaxzva
27 Apr 22
Business combination disclosure
5:26pm
8-K
EX-99.2
bro bdv94a51g77anh
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-99.2
ljxrg
22 Mar 22
Caladrius Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
4:09pm
8-K
EX-99.2
5yymfeoc9wydumbj
4 Nov 21
Caladrius Biosciences Provides Corporate Update and Reports 2021 Third Quarter Financial Results
4:09pm
8-K
EX-99.2
p35p1
5 Aug 21
Caladrius Biosciences Reports Second Quarter 2021 Financial Results and Provides Business Update
4:09pm
8-K
EX-10.1
a2v4ng9xd 22ar4
4 Jun 21
Entry into a Material Definitive Agreement
4:44pm